NEW YORK, Jan. 21 (Xinhua) -- Infrastructure grants totaling 38 million U.S. dollars were announced on Thursday to fund applied research and development facilities at four of New York City's leading scientific research institutions: Columbia University, Montefiore-Einstein, the New York Stem Cell Foundation, and Rockefeller University, according to the city government.
This is part of LifeSci NYC, a 500-million-dollar commitment to help establish the city as the public health capital of the world. Each facility will be dedicated to facilitating partnerships between New York's leading academic scientists, and biotech and pharmaceutical companies, with the ultimate goal of advancing innovative treatments for patients and growing the local industry, said an official release.
"New York City has fought back COVID-19 by trusting science and working closely with our partners in the scientific community. That work is only just beginning," Mayor Bill de Blasio was quoted as saying.
"As we rebuild a fairer and better city, it's time to make New York City a global leader in pandemic response. This city will stand with the life sciences in good times and bad, and I can't wait to see what our world-class partners will create in the years to come," he added.
LifeSci NYC's investments span three areas: connecting research to industry, unlocking space for life sciences growth, and building a diverse pipeline of industry talent in NYC. It is expected to create nearly 16,000 new jobs by 2026, many accessible to New Yorkers without advanced degrees.
Did you find this article insightful?
